The use of intrathecal midazolam in humans: A case study of process

Anesthesia and Analgesia

Volumn 98, Issue 6, 2004, Pages 1536-1545

  Yaksh, Tony L ^a,b   Allen, Jeffrey W ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE; BICUCULLINE; BUPIVACAINE; CLONIDINE; DIZOCILPINE; FLUMAZENIL; KETAMINE; LIDOCAINE; MIDAZOLAM; MORPHINE; NALOXONE; OMEGA CONOTOXIN MVIIA; PICROTOXIN; SODIUM CHLORIDE;

ANALGESIA; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SPASTICITY;

EID: 2442673083     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000122638.41130.BF     Document Type: Review

References (94)

1. Johansen MI, Gradert TL, Satterfield WC, et al. Safety and efficacy of continuous intrathecal midazolam infusion in the sheep model. Anesth Analg 2004;98:1528-35.
2. Tucker AP, Lai C, Nadeson R, Goodchild CS. Intrathecal midazolam I: a cohort study investigating safety. Anesth Analg 2004; 98:1512-20.
3. Tucker AP, Mezzatesta J, Nadeson R, Goodchild CS. Intrathecal midazolam II: combination with intrathecal fentanyl for labor pain. Anesth Analg 2004;98:1521-7.
4. Walser A, Benjamin LE Sr, Flynn T, et al. Quinazolines and 1,4-benzodiazepines. 84. Synthesis and reactions of imidaz[1,5-a][1,4]benzodiazepines. J Org Chem 1978;43:936-44.
5. Young CC, Prielipp RC. Benzodiazepines in the intensive care unit. Crit Care Clin 2001;17:843-62.
6. Liu LL, Gropper MA. Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection. Drugs 2003;63:755-67.
7. Curtis DR, Felix D. GABA and prolonged spinal inhibition. Nat New Biol 1971;231:187-8.
8. De Groat WC. GABA-depolarization of a sensory ganglion: antagonism by picrotoxin and bicuculline. Brain Res 1972;38: 429-32.
9. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery. Drug Discov Today 2003;8:445-50.
10. A channel subtypes. Mol Neurobiol 1998;18:35-86.
11. Rudomin P. Selectivity of the central control of sensory information in the mammalian spinal cord. Adv Exp Med Biol 2002; 508:157-70.
12. Wisden W, Gundlach AL, Barnard EA, et al. Distribution of GABAA receptor subunit mRNAs in rat lumbar spinal cord. Brain Res Mol Brain Res 1991;10:179-83.
13. A-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 1996;16: 283-97.
14. Kohno T, Kumamoto E, Baba H, et al. Actions of midazolam on GABAergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Anesthesiology 2000;92:507-15.
15. Whitwam JG, Niv D, Loh L, Jack RD. Depression of nociceptive reflexes by intrathecal benzodiazepine in dogs. Lancet 1982;2: 1465.
16. Niv D, Whitwam JG, Loh L. Depression of nociceptive sympathetic reflexes by the intrathecal administration of midazolam. Br J Anaesth 1983;55:541-7.
17. Gaumann DM, Yaksh TL, Tyce GM. Effects of intrathecal morphine, clonidine, and midazolam on the somato-sympathoadrenal reflex response in halothane-anesthetized cats. Anesthesiology 1990;73:425-32.
18. Muller H, Gerlach H, Boldt J, et al. Spasticity treatment with spinal morphine or midazolam: in vitro experiments, animal studies and clinical studies on compatibility and effectiveness. Anaesthesist 1986;35:306-16.
19. Goodchild CS, Serrao JM. Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. Br J Anaesth 1987;59: 1563-70.
20. Nishiyama T, Hanaoka K. The synergistic interaction between midazolam and clonidine in spinally-mediated analgesia in two different pain models of rats [erratum in Anesth Analg 2002;94: 254]. Anesth Analg 2001;93:1025-31.
21. Nishiyama T, Hanaoka K. The synergistic interaction between midazolam and clonidine in spinally-mediated analgesia in two different pain models of rats [erratum in Anesth Analg 2002;94: 254]. Anesth Analg 2001;93:1025-31.
22. Yaksh TL. Preclinical models of nociception. In: Yaksh TL, Lynch C III, Zapol WM, et al., eds. Anesthesia: biologic foundations. Philadelphia: Lippincott-Raven, 1997:685-718.
23. Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999;20:329-37.
24. Schwieger IM, Jorge-Costa M, Pizzolato GP, et al. Intrathecal midazolam reduces isoflurane MAC and increases the apnoeic threshold in rats. Can J Anaesth 1994;41:144-8.
25. Dirig DM, Yaksh TL. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 1995;275:219-27.
26. Przesmycki K, Dzieciuch JA, Czuczwar SJ, Kleinrok Z. Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur J Pharmacol 1997;337:11-7.
27. Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 1997;280: 829-38.
28. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994;269:1117-23.
29. Eisenach IC, Tong CY. Site of hemodynamic effects of intrathecal alpha 2-adrenergic agonists. Anesthesiology 1991;74:766-71.
30. Bolam JM, Robinson CJ, Hofstra TC, Wurster RD. Changes in micturition volume thresholds in conscious dogs following spinal opiate administration. J Auton Nerv Syst 1986;16:261-77.
31. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 1990;73:273-7.
32. Kyles AE, Waterman AE, Livingston A. Antinociceptive activity of midazolam in sheep. J Vet Pharmacol Ther 1995;18:54-60.
33. Nadeson R, Guo Z, Porter V, et al. Gamma-aminobutyric acid A receptors and spinally mediated antinociception in rats. J Pharmacol Exp Ther 1996;278:620-6.
34. Serrao JM, Goodchild CS, Gent JP. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine and midazolam. Eur J Anaesthesiol 1991;8:401-6.
35. Nishiyama T, Hanaoka K. Midazolam can potentiate the analgesic effects of intrathecal bupivacaine on thermal- or inflammatory-induced pain. Anesth Analg 2003;96:1386-91.
36. Yanez A, Sabbe MB, Stevens CW, Yaksh TL. Interaction of midazolam and morphine in the spinal cord of the rat. Neuropharmacology 1990;29:359-64.
37. Plummer JL, Cmielewski PL, Gourlay GK, et al. Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in rats. Pain 1992;49:145-52.
38. Rattan AK, McDonald JS, Tejwani GA. Differential effects of intrathecal midazolam on morphine-induced antinociception in the rat: role of spinal opioid receptors. Anesth Analg 1991;73: 124-31.
39. Luger TJ, Hayashi T, Weiss CG, Hill HF. The spinal potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur J Pharmacol 1995;275: 153-62.
40. Bailey PL, Pace NL, Ashburn MA, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990;73:826-30.
41. Rattan AK, Sribanditmongkol P. Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol Biochem Behav 1994; 48:357-61.
42. Gueye PN, Borron SW, Risede P, et al. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol Sci 2002;65:107-14.
43. Grouls RJE, Korsten EHM, Yaksh TL. General considerations for the formulation of drugs for spinal delivery. In: Yaksh TL, ed. Spinal drug delivery. Amsterdam: Elsevier Science B.V., 1999: 371-93.
44. Loftsson T, Gudmundsdottir H, Sigurjonsdottir JF, et al. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm 2001;212:29-40.
45. Borner U, Muller H, Zierski J, et al. CSF compatibility of antispasticity agents. In: Muller J, Zierski J, Penn RD, eds. Local-spinal therapy of spasticity. Berlin: Springer Verlag, 1986:81-4.
46. Nishiyama T, Sugai N, Hanaoka K. In vitro changes in the transparency and pH of cerebrospinal fluid caused by adding midazolam. Eur J Anaesthesiol 1998;15:27-31.
47. Vermeire A, Remon JP. Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, or methylprednisolone. Int J Pharm 1998;174:157-77.
48. Eisenach JC, Yaksh TL. Safety in numbers: how do we study toxicity of spinal analgesics? Anesthesiology 2002;97:1047-9.
49. Yaksh TL, Rathbun ML, Provencher JC. Preclinical safety evaluation for spinal drugs. In: Yaksh TL, ed. Spinal drug delivery. Amsterdam: Elsevier Science B.V., 1999:417-37.
50. Gerlach H, Muller H, Boldt J, Hemmpelmann G. Animal experiments on the spinal action of midazolam. In: Muller H, Zieski J, Pennn RP, eds. Local spinal therapy of spasticity. New York: Springer-Verlag, 1986:51-64.
51. Malinovsky JM, Cozian A, Lepage JY, et al. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology 1991;75: 91-7.
52. Erdine S, Yucel A, Ozyalcin S, et al. Neurotoxicity of midazolam in the rabbit. Pain 1999;80:419-23.
53. Malinovsky JM, Lepage JY, Cozian A, et al. Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology 1993;78:109-15.
54. Malinovsky JM, Benhamou D, Alafandy M, et al. Neurotoxicological assessment after intracistemal injection of liposomal bupivacaine in rabbits. Anesth Analg 1997;85:1331-6.
55. Malinovsky JM. Is intrathecal midazolam safe? Can J Anaesth 1997;44:1321-2.
56. Bozkurt P, Tunali Y, Kaya G, Okar I. Histological changes following epidural injection of midazolam in the neonatal rabbit. Paediatr Anaesth 1997;7:385-9.
57. Bahar M, Cohen ML, Grinshpon Y, Chanimov M. Spinal anaesthesia with midazolam in the rat. Can J Anaesth 1998;44:208-15.
58. Goodchild CS, Noble J. The effects of intrathecal midazolam on sympathetic nervous system reflexes in man: a pilot study. Br J Clin Pharmacol 1987;23:279-85.
59. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med 2000;25:117-57.
60. Niv D, Davidovich S, Geller E, Urca G. Analgesic and hyperalgesic effects of midazolam: dependence on route of administration. Anesth Analg 1988;67:1169-73.
61. Klockgether T, Schwarz M, Wullner U, et al. Myorelaxant effect after intrathecal injection of antispastic drugs in rats. Neurosci Lett 1989;97:221-6.
62. Serrao JM, Stubbs SC, Goodchild CS, Gent JP. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects [erratum in Anesthesiology 1989;71:482]. Anesthesiology 1989;70:780-6.
63. Serrao JM, Stubbs SC, Goodchild CS, Gent JP. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects [erratum in Anesthesiology 1989;71:482]. Anesthesiology 1989;70:780-6.
64. Gonzalez-Darder JM, Gomez-Cardenas E, Segura-Pastor D, Carrasco MS. Analgesic and anticonvulsive effect of midazolam via intrathecal administration in the rat. Rev Esp Anestesiol Reanim 1990;37:261-4.
65. Schoeffler P, Auroy P, Bazin JE, et al. Subarachnoid midazolam: histologic study in rats and report of its effect on chronic pain in humans. Reg Anesth 1991;16:329-32.
66. Aigouy L, Fondras JC, Pajot J, et al. Intrathecal midazolam versus intrathecal morphine in orofacial nociception: an experimental study in rats. Neurosci Lett 1992;139:97-9.
67. Yanez A, Peleteiro R, Camba MA. Intrathecal administration of morphine, midazolam, and their combination in 4 patients with chronic pain. Rev Esp Anestesiol Reanim 1992;39:40-2.
68. Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain 1992;48:5-12.
69. Crawford ME, Jensen FM, Toftdahl DB, Madsen JB. Direct spinal effect of intrathecal and extradural midazolam on visceral noxious stimulation in rabbits. Br J Anaesth 1993;70:642-6.
70. Luger TJ, Hayashi T, Lorenz IH, Hill HF. Mechanisms of the influence of midazolam on morphine antinociception at spinal and supraspinal levels in rats. Eur J Pharmacol 1994;271:421-31.
71. Aguilar JL, Espachs P, Roca G, et al. Difficult management of pain following sacrococcygeal chordoma: 13 months of subarachnoid infusion. Pain 1994;59:317-20.
72. Luger TJ, Lorenz IH, Grabner-Weiss C, Hayashi T. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats. Br J Pharmacol 1995;114:1097-103.
73. Schwarz M, Schmitt T, Pergande G, Block F. N-methyl-D-aspartate and alpha 2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 1995;276:247-55.
74. Naguib M, Gammal M, Elhattab YS, Seraj M. Midazolam for caudal analgesia in children: comparison with caudal bupivacaine. Can J Anaesth 1995;42:758-64.
75. Goodchild CS, Guo Z, Musgreave A, Gent JP. Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors. Br J Anaesth 1996;77:758-63.
76. Borg PA, Krijnen HJ. Long-term intrathecal administration of midazolam and clonidine. Clin J Pain 1996;12:63-8.
77. Valentine JM, Lyons G, Bellamy MC. The effect of intrathecal midazolam on post-operative pain. Eur J Anaesthesiol 1996;13: 589-93.
78. Hashimoto K, Karasawa F, Satoh T. Intrathecal midazolam attenuates renal sympathetic nerve activity in rabbits. Masui 1997; 46:1059-65.
79. Güleç S, Büyükkidan B, Oral N, et al. Comparison of caudal bupivacaine, bupivacaine-morphine and bupivacaine-midazolam mixtures for post-operative analgesia in children. Eur J Anaesthesiol 1998;15:161-5.
80. Nishiyama T, Gyermek L, Lee C, et al. Analgesic interaction between intrathecal midazolam and glutamate receptor antagonists on thermal-induced pain in rats. Anesthesiology 1999;91: 531-7.
81. Nishiyama T, Matsukawa T, Hanaoka K. Acute phase histopathological study of spinally administered midazolam in cats. Anesth Analg 1999;89:717-20.
82. Batra YK, Jain K, Chari P, et al. Addition of intrathecal midazolam to bupivacaine produces better post-operative analgesia without prolonging recovery. Int J Clin Pharmacol Ther 1999; 37:519-23.
83. Taira Y, Nakakimura K, Matsumoto M, Sakabe T. Spinal and supraspinal midazolam potentiates antinociceptive effects of isoflurane [erratum in Br J Anaesth 2001;86:301]. Br J Anaesth 2000;85:881-6.
84. Taira Y, Nakakimura K, Matsumoto M, Sakabe T. Spinal and supraspinal midazolam potentiates antinociceptive effects of isoflurane [erratum in Br J Anaesth 2001;86:301]. Br J Anaesth 2000;85:881-6.
85. Sen A, Rudra A, Sarkar SK, Biswas B. Intrathecal midazolam for postoperative pain relief in caesarean section delivery. J Indian Med Assoc 2001;99:683-4, 6.
86. Kim MH, Lee YM. Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. Br J Anaesth 2001;86:77-9.
87. Mahajan R, Batra YK, Grover VK, Kajal J. A comparative study of caudal bupivacaine and midazolam-bupivacaine mixture for post-operative analgesia in children undergoing genitourinary surgery. Int J Clin Pharmacol Ther 2001;39:116-20.
88. Rainov NG, Heidecke V, Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001;22:862-71.
89. Bharti N, Madan R, Mohanty PR, Kaul HL. Intrathecal midazolam added to bupivacaine improves the duration and quality of spinal anaesthesia. Acta Anaesthesiol Scand 2003;47:1101-5.
90. Baris S, Karakaya D, Kelsaha E, et al. Comparison of fentanylbupivacaine or midazolam-bupivacaine mixtures with plain bupivacaine for caudal anaesthesia in children. Paediatr Anaesth 2003;2:126-31.
91. Yaksh TL, Malkmus SA. Animal models of intrathecal and epidural drug delivery. In: Yaksh TL, ed. Spinal drug delivery. Amsterdam: Elsevier Science B.V., 1999:317-44.
92. Yaksh TL, Rathbun ML, Provencher JC. Preclinical safety evaluation for spinal drugs. In: Yaksh TL, ed. Spinal drug delivery. Amsterdam: Elsevier Science B.V., 1999:417-37.
93. Johnson ME. Potential neurotoxicity of spinal anesthesia with lidocaine. Mayo Clin Proc 2000;75:921-32.
94. Yaksh TL, Hassenbusch S, Burchiel K, et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002;3:300-12.